144 related articles for article (PubMed ID: 38242827)
21. Radiation-induced alterations in cytokine production by skin cells.
Müller K; Meineke V
Exp Hematol; 2007 Apr; 35(4 Suppl 1):96-104. PubMed ID: 17379094
[TBL] [Abstract][Full Text] [Related]
22. Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
Hart JP; Broadwater G; Rabbani Z; Moeller BJ; Clough R; Huang D; Sempowski GA; Dewhirst M; Pizzo SV; Vujaskovic Z; Anscher MS
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1448-54. PubMed ID: 16115739
[TBL] [Abstract][Full Text] [Related]
23. Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan.
Okamoto I
Int J Clin Oncol; 2008 Apr; 13(2):112-6. PubMed ID: 18463953
[TBL] [Abstract][Full Text] [Related]
24. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis.
Epperly MW; Travis EL; Sikora C; Greenberger JS
Biol Blood Marrow Transplant; 1999; 5(4):204-14. PubMed ID: 10465100
[TBL] [Abstract][Full Text] [Related]
25. Cytokine, chemokine alterations and immune cell infiltration in Radiation-induced lung injury: Implications for prevention and management.
Guo H; Yu R; Zhang H; Wang W
Int Immunopharmacol; 2024 Jan; 126():111263. PubMed ID: 38000232
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.
Tian Y; Ma J; Jing X; Zhai X; Li Y; Guo Z; Yu J; Zhu H
Cancer Lett; 2022 Aug; 541():215719. PubMed ID: 35597478
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Wang J; Xia TY; Wang YJ; Li HQ; Li P; Wang JD; Chang DS; Liu LY; Di YP; Wang X; Wu WZ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e59-65. PubMed ID: 21345607
[TBL] [Abstract][Full Text] [Related]
28. Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
Stinchcombe TE; Bogart JA
Oncologist; 2012; 17(5):682-93. PubMed ID: 22531360
[TBL] [Abstract][Full Text] [Related]
29. Proton Therapy in Non-small Cell Lung Cancer.
Mesko S; Gomez D
Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
[TBL] [Abstract][Full Text] [Related]
30. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
31. Quercetin-3-Rutinoside alleviates radiation-induced lung inflammation and fibrosis via regulation of NF-κB/TGF-β1 signaling.
Verma S; Dutta A; Dahiya A; Kalra N
Phytomedicine; 2022 May; 99():154004. PubMed ID: 35219007
[TBL] [Abstract][Full Text] [Related]
32. Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Perez BA; Kim S; Wang M; Karimi AM; Powell C; Li J; Dilling TJ; Chiappori A; Latifi K; Rose T; Lannon A; MacMillan G; Saller J; Grass GD; Rosenberg S; Gray J; Haura E; Creelan B; Tanvetyanon T; Saltos A; Shafique M; Boyle TA; Schell MJ; Conejo-Garcia JR; Antonia SJ
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):425-435. PubMed ID: 33002543
[TBL] [Abstract][Full Text] [Related]
33. Role of radiation in extensive stage small cell lung cancer: a National Cancer Database registry analysis.
Sheikh S; Dey A; Datta S; Podder TK; Jindal C; Dowlati A; Efird JT; Machtay M; Biswas T
Future Oncol; 2021 Jul; 17(21):2713-2724. PubMed ID: 33960209
[TBL] [Abstract][Full Text] [Related]
34. Cytokines and radiation-induced pulmonary injuries.
Lierova A; Jelicova M; Nemcova M; Proksova M; Pejchal J; Zarybnicka L; Sinkorova Z
J Radiat Res; 2018 Nov; 59(6):709-753. PubMed ID: 30169853
[TBL] [Abstract][Full Text] [Related]
35. Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats.
Zhang X; Shin YK; Zheng Z; Zhu L; Lee IJ
Radiat Oncol; 2015 Sep; 10():195. PubMed ID: 26382926
[TBL] [Abstract][Full Text] [Related]
36. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
[TBL] [Abstract][Full Text] [Related]
37. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy.
Anscher MS; Kong FM; Jirtle RL
Lung Cancer; 1998 Feb; 19(2):109-20. PubMed ID: 9567247
[TBL] [Abstract][Full Text] [Related]
38. Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Schild SE; Fan W; Stinchcombe TE; Vokes EE; Ramalingam SS; Bradley JD; Kelly K; Pang HH; Wang X
J Thorac Oncol; 2019 Feb; 14(2):298-303. PubMed ID: 30292852
[TBL] [Abstract][Full Text] [Related]
39. The role of NLRP3 inflammasome activation in radiation damage.
Wei J; Wang H; Wang H; Wang B; Meng L; Xin Y; Jiang X
Biomed Pharmacother; 2019 Oct; 118():109217. PubMed ID: 31302424
[TBL] [Abstract][Full Text] [Related]
40. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta.
Fu XL; Huang H; Bentel G; Clough R; Jirtle RL; Kong FM; Marks LB; Anscher MS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):899-908. PubMed ID: 11429217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
